Page last updated: 2024-08-22

magnesium sulfate and Atrial Flutter

magnesium sulfate has been researched along with Atrial Flutter in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (22.22)	18.2507
2000's	5 (55.56)	29.6817
2010's	2 (22.22)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hofmann, R; Hönig, S; Kammler, J; Kypta, A; Leisch, F; Schmitt, B; Steinwender, C	1
Chawla, D; Coleman, CI; Ghatak, A; Kluger, J; Sood, N; Talati, R	1
Antonatos, D; Babalis, D; Christou, A; Kafkas, N; Katsanos, S; Nikolaou, N; Patsilinakos, S; Spanodimos, S	1
Chung, JO; Kalus, JS; Kenyon, KW; Kluger, J; Spencer, AP; Tsikouris, JP; White, CM; Ziska, M	1
Bil'dinov, OA; Bregvadze, IN; Chazov, EI; Golitsyn, SP; Klimenko, IuL; Kratskina, TL; Maĭkov, EB; Rozenshtraukh, LV; Smirnova, MIu; Sokolov, SF	1
Coleman, CI; Kluger, J; Tercius, AJ; White, CM	1
Deshmukh, PK; Joshi, PP; Salkar, RG	1
Alstrup, P; Jensen, BM; Klitgård, NA	1
Arnold, DJ	1

Reviews

1 review(s) available for magnesium sulfate and Atrial Flutter

Article	Year
Intravenous magnesium for the treatment of cardiac arrhythmias. Australian and New Zealand journal of medicine, 2000, Volume: 30, Issue:1 Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Humans; Magnesium Sulfate; Tachycardia, Atrioventricular Nodal Reentry; Tachycardia, Ventricular	2000

Trials

5 trial(s) available for magnesium sulfate and Atrial Flutter

Article	Year
Pre-injection of magnesium sulfate enhances the efficacy of ibutilide for the conversion of typical but not of atypical persistent atrial flutter. International journal of cardiology, 2010, Jun-11, Volume: 141, Issue:3 Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Drug Synergism; Electrocardiography; Female; Heart Conduction System; Humans; Injections, Intravenous; Magnesium Sulfate; Male; Middle Aged; Placebo Effect; Prospective Studies; Sulfonamides; Treatment Outcome	2010
Effect of high doses of magnesium on converting ibutilide to a safe and more effective agent. The American journal of cardiology, 2010, Sep-01, Volume: 106, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cohort Studies; Drug Therapy, Combination; Female; Humans; Magnesium Sulfate; Male; Middle Aged; Sulfonamides; Torsades de Pointes; Treatment Outcome	2010
Intravenous magnesium sulfate enhances the ability of intravenous ibutilide to successfully convert atrial fibrillation or flutter. Pacing and clinical electrophysiology : PACE, 2007, Volume: 30, Issue:11 Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cohort Studies; Drug Therapy, Combination; Electrocardiography; Female; Humans; Injections, Intravenous; Magnesium Sulfate; Male; Middle Aged; Sulfonamides; Treatment Outcome	2007
Efficacy of intravenous magnesium sulphate in supraventricular tachyarrhythmias. The Journal of the Association of Physicians of India, 1995, Volume: 43, Issue:8 Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Blood Pressure; Female; Heart Rate; Humans; Infusions, Intravenous; Magnesium Sulfate; Male; Tachycardia, Supraventricular; Verapamil	1995
Magnesium substitution and postoperative arrhythmias in patients undergoing coronary artery bypass grafting. Scandinavian cardiovascular journal : SCJ, 1997, Volume: 31, Issue:5 Topics: Atrial Fibrillation; Atrial Flutter; Coronary Artery Bypass; Humans; Incidence; Magnesium Sulfate; Male; Middle Aged; Postoperative Complications; Time Factors; Water-Electrolyte Imbalance	1997

Other Studies

3 other study(ies) available for magnesium sulfate and Atrial Flutter

Article	Year
Intravenous magnesium sulfate enhances the ability of dofetilide to successfully cardiovert atrial fibrillation or flutter: results of the Dofetilide and Intravenous Magnesium Evaluation. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2009, Volume: 11, Issue:7 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Calcium Channel Blockers; Cohort Studies; Drug Synergism; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Magnesium Sulfate; Male; Middle Aged; Phenethylamines; Retrospective Studies; Sulfonamides; Treatment Outcome	2009
Impact of prophylactic i.v. magnesium on the efficacy of ibutilide for conversion of atrial fibrillation or flutter. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2003, Nov-15, Volume: 60, Issue:22 Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Chemoprevention; Cohort Studies; Drug Synergism; Female; Humans; Infusions, Intravenous; Magnesium Sulfate; Male; Middle Aged; Retrospective Studies; Sulfonamides; Treatment Outcome	2003
[The efficacy and safety of nibentan for pharmacological cardioversion in patients with persistent atrial fibrillation and flutter: the role of dose limitation and magnesium sulfate administration]. Kardiologiia, 2007, Volume: 47, Issue:3 Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Benzamides; Data Interpretation, Statistical; Electrocardiography; Female; Humans; Magnesium Sulfate; Male; Middle Aged; Retrospective Studies; Time Factors; Torsades de Pointes; Treatment Outcome	2007